Advertisement
Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
Breaking Research:
Read or Listen to the Latest Reports From ICAAC/IDSA 2008 >>
Nevirapine (Viramune)
Overview
|
News
|
Research
|
For Pregnancy/Newborns
See also:
Adverse Events of HIV/HAART
|
Drug Interactions
Overview
A Clinical Overview of Nevirapine (Viramune)
(Regularly Updated)
To read PDF,
click here
From
U.S. National Institutes of Health
Prescribing Information for Nevirapine (Viramune) (PDF)
(June 2007)
From Boehringer Ingelheim
Drug Interactions: Nevirapine
(February 2002)
From
Project Inform
News
FDA Public Health Advisory for Nevirapine (Viramune)
(January 19, 2005)
From
U.S. Food and Drug Administration
Nevirapine Misinformation: Will It Kill?
(December 31, 2004)
From
AIDS Treatment News
South Africa Drops Recommendation of Single-Dose Nevirapine Monotherapy for Pregnant Women
(July 14, 2004)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug
(October 15, 2002)
In
CDC HIV/Hepatitis/STD/TB Prevention News Update
, from
U.S. Centers for Disease Control and Prevention
St. John's Wort Found to Lower Nevirapine Levels
(March 2, 2001)
From
Canadian AIDS Treatment Information Exchange
Nevirapine Warning on Post-Exposure Prophylaxis
(January 12, 2001)
In
AIDS Treatment News
, from
AIDS Treatment News
For Pregnancy/Newborns
Adding Viread + Emtriva to Single-Dose Viramune Cuts Resistance Risk for Pregnant Women
(November 17, 2007)
In
The Lancet
Six-Month Delay in Onset of Nevirapine-Based Antiretroviral Therapy Can Prevent Drug Resistance Following Single-Dose Nevirapine During Labor, Study Says
(January 11, 2007)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Nevirapine Resistance May Persist in Some Pregnant Women, Study Finds
(May 3, 2006)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Combination Therapy Might Be Better Choice Than Nevirapine Alone to Prevent Vertical HIV Transmission, Researchers Say
(February 25, 2005)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
The Risk of NNRTI Resistance Following Perinatal Nevirapine and Ramifications for Subsequent Antiretroviral Therapy Success
(January 2005)
Part of HIV JournalView's Top 10 Research Reports of 2004.
From
The Body PRO
Nevirapine Misinformation: Will It Kill?
(December 31, 2004)
From
AIDS Treatment News
Questions and Answers About the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV
(December 17, 2004)
The United States responds to concerns over the Ugandan HIVNET 012 study.
From
U.S. National Institute of Allergy and Infectious Diseases
Project Inform Defends the Use of Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV
(December 15, 2004)
To read PDF,
click here
From
Project Inform
Comments on Nevirapine Resistance, by Global Strategies for HIV Prevention
(November/December 2004)
Global Strategies is an international nonprofit organization focused specifically on aiding women and children at risk for HIV.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Pediatric AIDS Foundation on Single-Dose Nevirapine
(November/December 2004)
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Single-Dose Drugs May Be Effective, But They Can Jeopardize Long-Term Therapy
(November/December 2004)
Recent studies bring potentially bad news for HIV drugs with long half-lives.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Single-Dose Theory: A Historical Overview of the Use of Nevirapine to Prevent Mother-to-Child HIV Transmission
(November/December 2004)
Includes a critical analysis of the late-2004 controversy over the drug's use in pregnant women.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Time to Move On: More Questions About Single-Dose Nevirapine
(November/December 2004)
Two studies cast doubt on the overall cost-effectiveness of this strategy.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Nevirapine During Labor and in the Neonate Significantly Improves Zidovudine Prophylaxis for the Prevention of Perinatal HIV Transmission: Results of PHPT-2 First Interim Analysis
(July 12, 2002)
In
The XIV International AIDS Conference
, from
The Body PRO
BROWSE ALL TOPICS:
Clinical Management
Clinical Management
Clinical Management Home
Antiretroviral Therapy
Complications of HIV/HAART
Research & Development
Clinical Trials
More ...
Conference Coverage
Conference Coverage
Conference Coverage Home
CROI 2008
IDSA 2007
ICAAC 2007
IAS 2007
Previous Conferences
Upcoming Conferences
More ...
Epidemiology
Epidemiology
Epidemiology Home
Global Statistics
U.S. and Canada
Africa
Asia
Latin America, Caribbean
Western Europe
More ...
Transmission & Basic Science
Transmission & Basic Science
Transmission Home
HIV Pathogensis & Immunology
HIV Prevention
HIV Testing
Other STDs
HIV History
More ...
Professional Development
Professional Development
Professional Development Home
Training Resources
Treatment Education
News & Analysis
More ...
Policy & Activism
Policy & Activism
Policy & Activism Home
AIDS Drug Assistance Programs
Ryan White CARE Act
FDA Drug Review & Approval
Resource-Limited Countries
More ...
Advertisement